GlassScriptPhysician profile
Lisa E Abeshaus
NPI 1134194624
$1,056.42
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.43 · 2020: $36.19 · 2021: $136 · 2022: $309 · 2023: $429 · 2024: $59.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.31 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.37 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Exeltis, USA INC. | $142.80 | 2021-2024 | Slynd, Tyblume |
| Mayne Pharma Commercial LLC | $111.64 | 2022-2023 | |
| Agile Therapeutics, INC. | $75.80 | 2022-2023 | Twirla |
| Avion Pharmaceuticals | $69.18 | 2021-2023 | Balcoltra |
| Allergan, INC. | $56.75 | 2019-2020 | |
| Evofem Biosciences, INC. | $56.05 | 2021-2023 | Phexxi |
| Astellas Pharma US INC | $52.00 | 2021-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $47.09 | 2022 | |
| Merck Sharp & Dohme LLC | $44.36 | 2023-2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $42.82 | 2019-2021 | |
| Pfizer INC. | $29.74 | 2021-2023 | |
| Axonics, INC. | $28.44 | 2023 | Axonics, Bulkamid |
| Millicent US INC | $28.13 | 2023 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $16.15 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $14.97 | 2023 | Paragard T 380a |
| Myovant Sciences INC. | $14.77 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.75 | 2023 | Seglentis |
| Organon LLC | $13.50 | 2021 | |
| Bausch Health US, LLC | $13.48 | 2022 | |
| Daiichi Sankyo INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Abeshaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.